AKT is a kinase that regulates numerous cellular processes in the brain and mutations in AKT 14 are known to affect brain function. AKT is indirectly implicated in synaptic plasticity, but its direct 15 role has not been studied. Moreover, three highly related AKT isoforms are expressed in the 16 brain, but their individual roles are poorly understood. We find that each AKT isoform has a 17 unique expression pattern in the hippocampus, with AKT1 and AKT3 primarily in neurons but 18 displaying local differences, while AKT2 is in astrocytes. We also find isoform-specific roles for 19 AKT in multiple paradigms of hippocampal synaptic plasticity. AKT1, but not AKT2 or AKT3, is 20 required for L-LTP through regulating activity-induced protein synthesis. Interestingly, AKT 21 activity inhibits mGluR-LTD, with overlapping functions for AKT1 and AKT3. In summary, our 22 23 the hippocampus. 24 KEYWORDS AKT1, AKT2, AKT3, synaptic plasticity, L-LTP, mGluR-LTD, protein synthesis, 25 astrocytes 26
studies identify distinct expression patterns and roles in synaptic plasticity for AKT isoforms in
INTRODUCTION 28
Dysregulation of synaptic plasticity is implicated in cognitive and memory impairments 29 associated with many neurological diseases and psychiatric disorders, such as Alzheimer's 30 disease, schizophrenia, and intellectual disability. The AKT (Protein kinase B, PKB) signaling 31 pathway is thought to play a pivotal role in synaptic plasticity 1 . AKT is a central serine/threonine 32 kinase expressed in almost all cell types throughout the body and regulates cell growth, 33 proliferation and metabolism. In post-mitotic neurons, the AKT pathway has significant 34 functional impact on stress responses, neurotransmission and synaptic plasticity 2 . 35 Synaptic plasticity describes the specific modification of neuronal connections in 36 response to neural activity. A persistent increase in synaptic strength after stimulation is known 37 as long-term potentiation (LTP) while a decrease in synaptic strength is known as long-term 38 depression (LTD). Late-phase LTP (L-LTP) is a long-lasting form of LTP that requires changes 39 in gene expression and the synthesis of new proteins 3 . A form of LTD mediated by group 1 40 metabotropic glutamate receptors (mGluR-LTD) also requires protein synthesis 4 . Interestingly, 41
AKT plays an important role in the mammalian target of rapamycin (mTOR) pathway controlling 42 protein synthesis, and previous studies found that induction of L-LTP or mGluR-LTD in the 43 hippocampus leads to AKT activation measured by increased phosphorylation of serine 473 5, 6 . 44 AKT is a well-studied kinase that may play a central role in brain disorders 1 . However, 69 most studies examining AKT activity made no distinction between the activities of each isoform. 70
We hypothesized that AKT isoforms play distinct roles in synaptic plasticity. To test this, we first 71 examined the expression pattern of AKT1, AKT2 and AKT3 in the mouse hippocampus. We 72 found that AKT1 and AKT3 were distributed throughout somatic layers of the hippocampus, with 73 local differences in expression ( Fig. 1 ). AKT1 showed more intense immunoreactivity in the cell 74 body layer of area CA1 whereas AKT3 showed more intense staining in cell bodies within area 75 CA3 and the hilus of the dentate gyrus. Interestingly, AKT2 showed a very different staining 76 pattern. AKT2 was mostly expressed in cells of the molecular layer of the dentate gyrus and 77 stratum radiatum of CA1 ( Fig. 1 ). Isoform-specific KO tissues confirmed specificity of the 78 staining ( Fig. 1 ). Because the brain consists of neurons and glia cells, we next determined the 79 cell types in which each isoform is expressed by co-staining brain slices for the neuronal marker 80 neuron-specific nuclear protein (NeuN), the astrocytic marker glial fibrillary acidic protein 81 (GFAP) and each AKT isoform. This triple stain approach revealed that within CA1, AKT1 was 82 mainly expressed in pyramidal layer neurons, with no detectable staining in astrocytes ( Fig.  83 2a,b). Interestingly, certain neurons seemed to express more AKT1 compared with neighboring 84 neurons ( Fig. 2a,b ). In the CA1, AKT3 was also mainly expressed in neurons, including in the 85 processes extending into stratum radiatum, with some weak staining in astrocytes ( Fig. 2a,b) . 86 AKT2 showed no detectable co-localization with NeuN but co-localized with GFAP ( Fig. 2a,b) . 87
To confirm that AKT2 is not expressed in neurons, we employed a Cre-mediated strategy of 88 selective Akt2 gene disruption by crossing mice with floxed alleles of Akt2 to two different 89 mouse lines with neuron-specific Cre recombinase expression (Camk2α-Cre-T29 and NSE39-90 Cre). Using this strategy, we confirmed that AKT2 levels were not reduced in the hippocampus 91 with either Cre line, showing that Akt2 is not expressed in hippocampal neurons (Supplementary 92 Fig. 1 ). To verify disruption of the floxed Akt2 alleles, hippocampi of Akt2 loxP/loxP mice were 93 infected with adeno-associated virus (AAV) constructs expressing EGFP-tagged Cre under the 94 weeks post-infection, we found that AKT2 levels were reduced in the hippocampus with CMV-96 driven Cre expression ( Supplementary Fig. 1 ), providing further support that AKT2 is expressed 97 in astrocytes and not in neurons. Combined, our results demonstrate differential AKT isoform 98 expression in the hippocampus. This isoform-specific expression may lead to unique functions 99 of each isoform in synaptic plasticity processes. 100
AKT inhibition leads to reduced substrate activity and impaired L-LTP 101
AKT has been implicated in L-LTP 16 , but directly targeting AKT in L-LTP had not been 102 studied. We chose to test the effects of two AKT inhibitors, AZD5363 (AZD) and MK2206-HCl 103 (MK), on synaptic plasticity. AZD and MK have different mechanisms of action; AZD is an ATP-104 competitive AKT inhibitor 17 and MK is an allosteric AKT inhibitor 18 . To examine AZD and MK 105 action in the brain, we first assessed their effects on the phosphorylation of AKT and a well-106 characterized downstream target of AKT, glycogen synthase kinase 3β (GSK-3β) in 107 hippocampal slices. Incubation with 10 µM MK strongly inhibited AKT activity as measured by 108 the reduction of AKT phosphorylated on serine 473 (pAKT S473); however, phosphorylation 109 levels of GSK-3β on serine 9 (pGSK-3β S9) were not reduced ( Fig. 3a-c) . At higher doses of 110 MK (30 µM and 100 µM), pAKT continued to be reduced at similar levels ( Fig. 3a,b ) while 111 pGSK-3β levels were ultimately reduced in a dose-dependent manner (Fig. 3a,c) . AZD 112 incubation resulted in increased pAKT levels ( Fig. 3a,b ), consistent with previous reports that 113 ATP-competitive inhibitors of AKT result in hyperphosphorylation of the kinase itself, which does 114 not indicate increased AKT activation but likely reflects intrinsic responses to competitive 115 inhibition of AKT 19 . Indeed, AZD significantly decreased phosphorylation levels of the AKT 116 target GSK-3β in a dose-dependent manner, indicating AZD inhibited AKT activity (Fig. 3a,c) . 117 ( Fig. 3a,d ). Based on the dose response of pGSK-3β S9 levels, we chose to test 30 µM for both 120 AZD and MK inhibitors on synaptic plasticity in the CA3-CA1 circuit of the hippocampus. After 121 determining that incubation of hippocampal slices from wild-type (WT) mice with either inhibitor 122 did not affect the stability of baseline field excitatory postsynaptic potentials (fEPSP) recorded in 123 CA1 ( Supplementary Fig. 2) , we assessed the effect on expression of L-LTP induced by high 124 frequency stimulation (HFS). We found that both AKT inhibitors resulted in significantly impaired 125 L-LTP compared with vehicle treatment (Fig. 4a,b ), indicating that AKT activity is required to 126 sustain long-lasting LTP in area CA1. 127
Loss of AKT1 leads to impaired L-LTP 128
To determine if a specific AKT isoform may be responsible for maintaining L-LTP in the 129 CA3-CA1 circuit, we examined hippocampal slices from Akt1, Akt2 or Akt3 KO mice ( Fig. 4c ). 130
Because AKT has been linked to AMPA and NMDA receptor function 20 , we first examined the 131 effect of deleting single Akt isoforms on basal synaptic transmission, presynaptic plasticity and 132 short-term LTP in area CA1. We found normal synaptic input/output curves ( Supplementary Fig.  133 3), paired-pulse facilitation ( Supplementary Fig. 3 ) and E-LTP ( Supplementary Fig. 4 ) in all 134 single Akt isoform mutants, suggesting no one isoform is required for normal basal synaptic 135 transmission, presynaptic plasticity and short-term LTP. In contrast, we found that Akt1 deletion 136 resulted in impaired L-LTP ( Fig. 4d ), while slices from Akt2 or Akt3 KO mice showed normal L-137 LTP ( Fig. 4e ,f). This shows that AKT1 is the major isoform involved in the expression of L-LTP 138 and targeted by AZD and MK inhibition to impair L-LTP in CA1. 139
Akt1 deletion results in impaired protein synthesis after L-LTP induction 140
Hippocampal L-LTP requires synthesis of proteins that are involved in modifying 141 synaptic connections 3 . Because the AKT pathway plays a well-known role in translational 142 control, the AKT1 isoform may function in L-LTP by regulating protein synthesis. Interestingly, 143 even though Akt3 removal had no effect on L-LTP, Akt3 KO mice have significantly smaller 144 brains, which may indicate impaired translation. To examine protein synthesis associated with 145 L-LTP in Akt1 and Akt3 KO hippocampal slices, we used the SuNSET method of labeling newly 146 synthesized proteins 21 . Slices from Akt1 or Akt3 KO and WT littermates received either four 147 spaced trains of HFS to induce L-LTP or no stimulation (control). Western blotting showed that 148
Akt1 KO slices failed to increase protein synthesis following L-LTP induction (Fig. 5a ,c), 149 consistent with the L-LTP impairment observed in these slices ( Fig. 4d ). In contrast, Akt3 150 deletion did not affect the protein synthesis response post-HFS ( Fig. 5b,d ), which is consistent 151 with the normal L-LTP found in Akt3 KO slices ( Fig. 4f ). These results suggest an isoform-152 specific role for AKT1 in activity-induced protein synthesis that promotes L-LTP expression in 153 the hippocampus. 154
To investigate the molecular signaling pathways linking AKT activity to translational 155 control in long-lasting synaptic plasticity, we examined the phosphorylation levels of a well-156 known AKT effector, S6. S6 is a component of the 40S ribosomal subunit that mediates 157 translation, and phosphorylation of S6 at serine 235 and 236 (pS6) is essential for S6 cap-158 binding activity 22 . We found that pS6 levels significantly increased after tetanic stimulation in 159 WT and Akt3 KO hippocampal slices but not in Akt1 KO slices ( Fig. 5e-h ). This result agrees 160 with the impaired protein synthesis after tetanic stimulation observed with AKT1 deficiency. 161 Therefore, AKT1 is the critical isoform supporting hippocampal L-LTP through activity-regulated 162 signaling to protein synthesis and may compensate for AKT3 to enable normal L-LTP and 163 associated protein synthesis in Akt3 KO conditions. 164
AKT activity is not required for LTD induced by low frequency stimulation 165
Another form of synaptic plasticity is LTD induced by low frequency stimulation (LFS-166 LTD), which is known to depend on NMDA receptor-mediated calcium influx and is independent 167 of protein synthesis 4 . Previously, synaptic plasticity related to brain-derived neurotrophic factor 168 signaling was reported to involve a feedforward AKT mechanism to NMDA receptors 15 . 169 Furthermore, the AKT substrate GSK-3β was found to be important for LFS-LTD, and 170 phosphorylation levels of GSK-3β was found to be reduced in Akt3 KO brains 23, 24 . We 171 confirmed that Akt3 deletion results in decreased hippocampal levels of pGSK-3β ( Fig. 6a ). In 172 contrast, Akt1 KO mice show normal pGSK-3β levels ( Fig. 6a ), revealing further differential AKT 173 isoform signaling. Therefore, AKT activity, especially AKT3, may be involved in maintaining 174 LFS-LTD. To address this question, we examined LFS-LTD in the CA3-CA1 circuit of single Akt 175 isoform mutant slices and found no effect of any single isoform deletion ( Fig. 6b-d ). To 176 determine if these findings resulted from incomplete blockade of AKT activity or if multiple 177 isoforms are involved, we examined LFS-LTD in WT hippocampal slices following 178 pharmacological inhibition of AKT activity using AZD or MK. We found normal expression of 179 LFS-LTD compared to vehicle-treated slices ( Fig. 6e ,f). Therefore, these experiments combined 180 indicate that AKT is not required for LFS-LTD in CA1. 181
Inhibition of AKT activity leads to enhanced mGluR-LTD 182
Previous studies suggest AKT is involved in another form of LTD, which is mediated by 183 mGluR (mGluR-LTD) and depends on protein synthesis 25 . Upon mGluR stimulation with DHPG, 184 pAKT S473 levels were shown to increase, suggesting increased AKT activity 5 . Also, inhibiting 185 phosphoinositide 3-kinase (PI3K) activity, a well-validated kinase upstream of AKT activation 26 , 186 results in impaired mGluR-LTD 5 . However, direct interrogation of the role of AKT in mGluR-LTD 187 expression had never been performed. Thus, we directly examined AKT function in mGluR-LTD 188 using the pan-AKT inhibitors AZD and MK and Akt mutants. 189
We incubated WT hippocampal slices with AKT inhibitors prior to mGluR-LTD induction 190 with DHPG 27 . Unexpectedly, we found that inhibiting AKT activity with either AZD or MK 191 enhanced mGluR-LTD ( Fig. 7a,b ). Because a previous report using LY294002 inhibition of 192 PI3K, a major upstream activator of AKT 28 , showed impaired mGluR-LTD 5 , we had expected to 193 find that direct AKT inhibition also would impair mGluR-LTD 5 . We therefore repeated the 194 experiment with LY294002. In agreement with our MK and AZD data, we found that inhibition of 195 PI3K resulted in enhanced mGluR-LTD ( Fig. 7c ). These results demonstrate that AKT is indeed 196 involved in regulating mGluR-LTD, although in a different manner than we expected. 197
To investigate isoform-specific contributions to this phenotype, we next induced mGluR-198 LTD in Akt1, Akt2 or Akt3 KO hippocampal slices. Interestingly, we found that all single isoform 199 mutant slices displayed normal mGluR-LTD ( Fig. 7d-f ). Because pan-AKT and PI3K inhibition 200 both resulted in enhanced mGluR-LTD ( Fig. 7a-c) , two or more isoforms may redundantly 201 compensate for each other to allow normal expression of mGluR-LTD in the single Akt isoform 202 mutants. To test this idea, we generated multiply mutant Akt mice. 203
Akt1/Akt3 double mutants have enhanced mGluR-LTD 204
Because Akt1 and Akt3 are the more similarly expressed isoforms in the hippocampus, 205 we hypothesized that AKT1 and AKT3 may substitute for each other in regulating mGluR-LTD 206 expression at CA3-CA1 synapses. Therefore, combined Akt1 and Akt3 deletion may result in 207 enhanced mGluR-LTD, reproducing the effect of pan-AKT inhibition with either AZD or MK. 208
Because Akt1/Akt3 double KO mice are embryonic lethal 12 , we used a Cre-mediated strategy of 209 selective Akt1 disruption by crossing mice with floxed alleles of Akt1 to a forebrain-specific 210 neuronal Cre recombinase mouse line (T29) in an Akt3 KO background (cA1F/A3K mice) ( Fig.  211 8a). Using this strategy, AKT3 is removed and AKT1 levels are significantly reduced in the 212 hippocampus of cA1F/A3K mice compared with WT mice (Fig. 8b,c) . Immunostaining of the 213 hippocampus showed Akt1 was mostly deleted from excitatory pyramidal neurons in area CA1, 214 while other neurons, most likely inhibitory neurons, still expressed AKT1 ( Fig. 8d ). Next, we 215 examined mGluR-LTD in cA1F/A3K mice. Consistent with our results from the AKT inhibitor 216 experiments, we found that mGluR-LTD was enhanced in cA1F/A3K mice compared with WT 217 mice ( Fig. 8e ). Thus, concomitant Akt1 and Akt3 deletion results in enhanced mGluR-LTD, 218 supporting the idea that the AKT1 and AKT3 isoforms function in hippocampal mGluR-LTD and 219 can compensate for each other. 220
DISCUSSION 221
Our studies discovered novel distinct roles for the different Akt isoforms in the brain. We 222 show, for the first time, that AKT2 expression is localized to astrocytes in the hippocampus, 223 while AKT1 and AKT3 are primarily but differentially expressed in neurons. We also show for 224 the first time that these differences in isoform expression are associated with different functions 225 in the brain involving synaptic plasticity. We demonstrate that the AKT1 isoform is critical for the 226 expression of L-LTP and regulating activity-induced protein synthesis that supports L-LTP. 227
Interestingly, in contrast to the apparent singular requirement for AKT1 in L-LTP, we found that 228 AKT1 and AKT3 serve overlapping roles to inhibit the expression of mGluR-LTD. To our 229 knowledge, this is the first study to identify AKT isoform-specific expression in the hippocampus 230 and AKT isoform-specific activity underlying different forms of hippocampal synaptic plasticity. 231
Because AKT controls numerous cellular processes, uncovering isoform differences is 232 important to improve understanding about normal AKT function. Moreover, isoform-specific 233 roles for AKT have been associated with different disease pathologies. The AKT2 isoform, for 234 example, has been implicated in diabetes. A missense mutation in AKT2 that causes loss of 235 AKT2 function leading to insulin resistance was identified in a family with diabetes 29 . Similarly, 236 AKT2-deficient mice have resistance to insulin and a subset develop diabetes mellitus-like 237 syndrome 13 . AKT2 also has been associated glioma, a type of brain cancer with malignant 238 tumors derived from glial cells. High-grade gliomas have been shown to overexpress AKT2 9 . 239
Although this correlation suggests a role for AKT2 in astrocytic function, we were still surprised 240 that our immunostaining in the hippocampus showed AKT2 only to be present in astrocytes. 241
Close examination of our immunostaining revealed little or no detectable AKT1 and AKT3 242 expression in astrocytes (Fig. 2) , although we cannot exclude that they may be present. A 243 previous study using primary astrocytic culture derived from developing mouse brain tissue 244 showed that all three isoforms were expressed in cortical astrocytes 30 . Therefore, it may be 245 possible that AKT2 expression is restricted to hippocampal astrocytes or becomes restricted 246 post-developmentally or that signals from other brain cell types in vivo restrict AKT2 expression 247 to astrocytes. Although we found no evidence of a role for AKT2 in the synaptic plasticity 248 paradigms tested in this study, AKT2 might play a role in synaptic plasticity as it relates to 249 astrocytic function for supporting neuronal activity 31 . 250
The AKT1 isoform specifically has been linked to schizophrenia, a neurological disorder 251 believed to represent brain dysconnectivity with a molecular basis in aberrant synaptic plasticity 252 32 . AKT1 is one of the effectors in the well-established pathway from neuregulin 1 (NRG1-253 ERBB4-PI3K-AKT1 pathway), where each of these components have genetic polymorphisms 254 that have been linked to schizophrenia 8, 33 . These polymorphisms may lead to lower AKT1 255 protein levels in schizophrenia 8, 34 , although increased AKT1 expression and activity also have 256 been reported in schizophrenia 35, 36 . Human olfactory neurosphere-derived cells collected from 257 schizophrenia patients were shown to have reduced protein synthesis 37 . Additionally, the 258 antipsychotic haloperidol used to treat schizophrenia can activate the AKT pathway, thereby 259 inducing protein synthesis 38 . Together, these reports may suggest protein synthesis is reduced 260 in schizophrenia, which may be due to reduced AKT1 signaling. Because protein synthesis is 261 crucial to maintain L-LTP 3 , our finding that Akt1 deletion results in the impairment of L-LTP ( Fig.  262 4) and the associated protein synthesis response ( Fig. 5 ) suggests AKT1 may be an important 263 factor in the synaptic and cognitive deficits observed in schizophrenia 32 . 264
The AKT3 isoform is expressed in a highly overlapping pattern with AKT1 in the 265 hippocampus ( Fig. 1 ), suggesting overlapping roles with AKT1, but there are also notable 266 differences between their expression ( Fig. 1, 2 ). AKT3 is known to control brain size 11, 14 . 267
Mutations that result in enhanced AKT3 activity lead to increased brain growth 10 , while deletion 268 of AKT3 is involved in microcephaly 39 . AKT3 may control brain growth through regulation of 269 protein synthesis. Deletion of Akt3 is known to reduce phosphorylation of the ribosomal protein 270 S6 11 , which is an effector in the AKT-mTOR pathway leading to protein synthesis. Intriguingly, 271
our results show that only AKT1-deficient mice display impaired protein synthesis-dependent L-272 LTP, while deletion of Akt3 has no effect ( Fig. 4) . These data are consistent with the idea that 273 while both AKT1 and AKT3 can regulate neuronal protein synthesis, AKT1 is specifically 274 recruited to support translation involved in L-LTP. 275
What mechanisms might underlie the differential regulation of protein synthesis by AKT1 276 and AKT3? Phosphorylation of S6 on S235/236 is increased after L-LTP, which correlates with 277 increased translation 40 . Consistent with our finding that Akt1 deletion leads to an impaired 278 protein synthesis response, Akt1 KO slices fail to increase S6 phosphorylation following 279 stimulation, whereas Akt3 KO slices still display dynamic range in protein synthesis and S6 280 activation (Fig. 5) . These results show distinct roles for AKT1-and AKT3-mediated protein 281 synthesis. AKT1 is the activity-regulated isoform, converting external stimuli into protein 282 synthesis, while AKT3 may be more important for steady-state protein synthesis. This distinction 283 may also correlate with the regional differences we observed in hippocampal AKT1 and AKT3 284 expression ( Fig. 1, 2) . Thus, in regions where AKT3 expression predominates like area CA3, 285
Akt3 KO slices may show altered activity-induced protein synthesis, following stimulation of the 286 reported to have no effect on mGluR-LTD 42, 44 . Likewise, loss of S6K1 has been shown to have 299 no effect on mGluR-LTD, while S6K2 loss results in enhanced mGluR-LTD 45 . Some of these 300 divergent results may be due to methodological differences or the developmental stage at which 301 experiments were performed. However, it remains that none of these earlier studies directly 302 examined the role of AKT activity in mGluR-LTD. To address this gap, we targeted AKT directly 303 using multiple approaches, including pharmacological agents and genetic removal of Akt. 304
Our results strongly support the idea that AKT normally acts to inhibit mGluR-LTD. We 305 found that blockade of AKT activity with multiple separate approaches, using two different AKT 306 inhibitors, genetic deletion of both Akt1 and Akt3 in CA1 as well as PI3K inhibition, all resulted in 307 enhanced mGluR-LTD (Figs 7 and 8) . By using two AKT inhibitors that have different 308 mechanisms of action on AKT, complemented by genetically removing AKT, we addressed 309 potential off-target effects of the compounds and provide converging evidence that the 310 enhanced mGluR-LTD is due to specific inhibition of AKT. Developmental effects of AKT 311 removal also are unlikely to contribute to the observed LTD enhancement as single Akt isoform 312 deletion did not affect mGluR-LTD (Fig. 7) . Additionally, in the double Akt1/Akt3 deletion 313 experiment, AKT1 is removed postnatally, eliminating potential confounds from the loss of 314 multiple AKT isoforms during development. Combined, these data show that the role of AKT in 315 mGluR-LTD may be more complex than originally thought. AKT may not simply be a facilitator 316 of general mTORC1-mediated translation but may only be involved in regulating distinct pools of 317 mGluR-induced protein synthesis, some of which may act to inhibit mGluR-LTD. In agreement 318 with this idea, the AKT-TSC pathway has been suggested to act as a brake on mTOR-regulated 319 protein synthesis, while the extracellular-regulated kinase pathway, which is also activated by 320 mGluR stimulation, promotes protein synthesis 44 . In this case, AKT1 and AKT3 inhibition may 321 relieve the brake on protein synthesis after mGluR stimulation, leading to altered protein 322 synthesis or AMPA receptor internalization and subsequently enhanced mGluR-LTD. Future 323 studies examining these possibilities will be important to resolve the role of AKT in regulating 324 these important pathways in mGluR-LTD. 325
In summary, this study provides valuable new insights into the role of AKT and its 326 isoforms in the brain. The results show expression differences between AKT isoforms in the 327 hippocampus, affecting their role in synaptic plasticity and protein synthesis. Hence, compounds 328 targeting single AKT isoforms may be an attractive therapeutic target for treating disorders and 329 diseases that impact synaptic plasticity. 
FIGURE LEGENDS 468
Figure 1 AKT isoform-specific expression in the hippocampus. Immunohistology using isoform-469 specific antibodies revealed distinct expression patterns for each AKT isoform in the 470 hippocampus. AKT1 was mainly expressed in the cell body layers, with the greatest levels in 471 stratum pyramidale of CA1. AKT2 was mostly expressed in specific cells in the molecular layer 472 of the dentate gyrus, CA3 and CA1. AKT3 was also mainly expressed in the cell body layers of 473 the hippocampus and showed strong expression in the hilus and CA3. Bottom panels show 474 single Akt knockout (KO) tissue to validate the specificity of the antibodies. 475
Figure 2
Cell type-specific expression of AKT isoforms in hippocampal area CA1. (a). AKT1 476 was mainly expressed in neuronal cell bodies, indicated by co-localization with NeuN. Certain 477 neurons in the pyramidal layer, stratum oriens and molecular layer showed greater expression 478 levels of AKT1 (yellow arrows). AKT2 was specifically expressed in astrocytes, shown by co-479 localization with the astrocyte marker GFAP. AKT3 co-localized with NeuN like AKT1 but was 480 also expressed in the stratum radiatum, most likely within dendrites. (b) Higher magnification 481 showed no specific co-localization of AKT1 with GFAP and that certain neurons in the stratum 482 oriens expressed high levels of AKT1 (yellow arrows). AKT2 was mainly expressed in the cell 483 bodies of astrocytes. AKT3 showed high expression levels in neuronal cell bodies and dendrites 484 and some expression in astrocytes. 485 Akt1 KO 46 , Akt2 KO 13 and Akt3 KO 11 male mice were generated in the C57/BL6 background. 560
To generate mice that have conditional Akt1 or Akt2 removal in excitatory neurons in the 561 forebrain we bred Akt1 loxP/loxP 47 or Akt2 loxP/loxP 48 with Camk2α-Cre (T-29-1) 49 or NSE39-Cre (Jax 562 Labs) mice, all in the C57/BL6 background. Age-matched wild-type (WT) male littermates were 563 used as controls for this study. Mice were housed at 21 ˚C, maintained on a 12h light/dark 564 schedule with food and water available ad libitum and tested at 5-20 weeks of age, depending 565 on the experimental protocol. All procedures were approved by the University of Colorado, 566
Boulder Animal Care and Use Committee. 567
Stereotaxic surgery 568
AAV8-CMV_Cre-EGFP (Penn Vector Core) was introduced in the hippocampus of Akt2 loxP/loxP 569 and WT mice. Briefly, the mice were anaesthetized with a continuous supply of 1.5% isoflurane 570 gas and secured in a stereotaxic frame (Kopf Instruments). After confirming that the mice did 571 not respond to a toe pinch, an incision was made to expose the skull. The coordinates targeting 572 CA1 in the dorsal hippocampus were anteroposterior -1.94, lateromedial -1.75 mm, dorsoventral 573 -1.62 mm from bregma. AAV8-CMV_Cre-EGFP (1 µL of 1.01E 10 genome copies) was infused 574 unilaterally over 10 min at a rate of 0.1 µL/min through a 28-gauge injector (PlasticsOne) driven 575 by a syringe infusion pump (Harvard Apparatus). The injector remained in place for 10 min after 576 the infusion procedure to facilitate diffusion of the virus. After the injector was removed, the 577 incision was closed and each mouse was monitored while recovering from anesthesia. Three 578 weeks after AAV injections, dorsal hippocampal tissue was isolated and processed for 579 immunoblotting. 580 581 Immunohistology 582 WT and Akt mutant mice were anesthetized using a mixture of pentobarbital sodium and 583 phenytoin sodium (Euthanasia III). When they were unresponsive to a toe pinch, mice were 584 intracardially perfused with PBS followed by 4% paraformaldehyde (PFA). After perfusion, 585 brains were isolated and kept in 4% PFA for 24 h at 4ºC. Brains were then transferred to 30% 586 sucrose in PBS for at least 24 h at 4 ºC. Next, brains were sectioned into 30 µm coronal slices 587 on a cryostat (Leica) and stored at -20 ºC in cryoprotectant (20% glycerol/2% DMSO in 588 phosphate buffer) until used for immunohistology. Fluorescent immunostaining was performed 589 as described previously with minor changes 50 . Briefly, free-floating brain sections were washed 590 with PBS and submitted to heat-mediated antigen retrieval in citrate buffer (10 mM, pH 6) if 591 needed. Slices were blocked for 1 h at room temperature in staining buffer containing 0.05 M 592 Tris pH 7.4, 0.9% NaCl, 0.25% gelatin, 0.5% TritonX-100, and 2% donkey serum. Slices were 593 then incubated overnight at 4 ºC with primary antibodies against AKT1 (1:100, Cell Signaling 594 D9R8K), AKT2 (1:100, Cell Signaling 5B5), AKT3 (1:100, Cell Signaling E1Z3W), NeuN 595
(1:1000, Millipore Mab377), and GFAP (1:1000, PhosphoSolutions 621-GFAP) diluted in 596 staining buffer with 2% donkey serum. After three washes in PBS, the brain slices were 597 incubated at room temperature for 2 h in Cy3-conjugated anti-rabbit, 488-conjugated anti-mouse 598 and Cy5-conjugated anti-chicken secondary antibodies (1:200, Jackson Immunoresearch) 599 diluted in staining buffer with Hoechst dye (1:3000). Following three washes in PBS, slices were 600 mounted and coverslipped with Mowiol. Brain slices were imaged using the Nikon A1R confocal 601 microscope. Z-stacks through the entire thickness of the slice were taken at 20x and 100x. All 602 microscope parameters were held constant across all slices. 603 604
Field electrophysiology 605
Long-term potentiation (LTP) and long-term depression (LTD) in the CA3-CA1 circuit from acute 606 400-µm transverse hippocampal slices were recorded as previously described 49, 50 . 607 
